Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itziar Echeverria

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Virology|January 23, 2009
Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cellsEsther Larrea, Rafael Aldabe, Iranzu Gonzalez, et al.
Acta Crystallographica. Section A, Foundations and Advances|February 21, 2025
Sine Ydun Larsen (1943-2025)Sven Lidin, Malcolm J Cooper, Itziar Echeverria, et al.
Journal of Hepatology|January 15, 2014
Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infectionEsther Larrea, Itziar Echeverria, Jose-I Riezu-Boj, et al.
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinomaLaura Alaniz, Manglio Rizzo, Mariana G Garcia, et al.
Hepatology (Baltimore, Md.)|April 1, 2011
Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cellsItziar Echeverria, Alexander Pereboev, Leyre Silva, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infectionAintzane Zabaleta, Delia D'Avola, Itziar Echeverria, et al.
Hepatology (Baltimore, Md.)|December 15, 2010
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10Nancy Díaz-Valdés, Lorea Manterola, Virginia Belsúe, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Virology|January 23, 2009
Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cellsEsther Larrea, Rafael Aldabe, Iranzu Gonzalez, et al.
Acta Crystallographica. Section A, Foundations and Advances|February 21, 2025
Sine Ydun Larsen (1943-2025)Sven Lidin, Malcolm J Cooper, Itziar Echeverria, et al.
Journal of Hepatology|January 15, 2014
Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infectionEsther Larrea, Itziar Echeverria, Jose-I Riezu-Boj, et al.
Gut|June 22, 2013
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytesEsther Larrea, Jose-I Riezu-Boj, Rafael Aldabe, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinomaLaura Alaniz, Manglio Rizzo, Mariana G Garcia, et al.
Hepatology (Baltimore, Md.)|April 1, 2011
Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cellsItziar Echeverria, Alexander Pereboev, Leyre Silva, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infectionAintzane Zabaleta, Delia D'Avola, Itziar Echeverria, et al.
Hepatology (Baltimore, Md.)|December 15, 2010
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10Nancy Díaz-Valdés, Lorea Manterola, Virginia Belsúe, et al.
Pageof 1